Alliance Pharma PLC
30 March 2005
For immediate release: 30 March 2005
ALLIANCE PHARMA PLC
('Alliance' or 'the Company')
SHAREHOLDINGS IN COMPANY
Fidelity acquire an additional 3,700,000 ordinary shares
On 30th March 2005 the Company was notified by Fidelity Investments, ('FMR Corp
'), that it had increased its shareholding by 3,700,000 shares. The notifiable
interest is with FMR Corp and Fidelity International Limited (FIL) which also
comprises the notifiable interest of Mr Edward C Johnson 3d, a principal
shareholder of FMR Corp and Fidelity International Limited. The shares held
currently are as follows:
Shares Held Management Company Nominee/Registered Name
240,500 FIL Brown Brothers Harriman Ltd LUX
9,959,500 FMRCO Mellon Bank
TOTAL 10,200,000
The total percentage shareholding of FMR Corp and Fidelity International Limited
is now 9.43%
On 30th March 2005, the Company was also notified that F&C Asset Management has
ceased to have a notifiable interest in the Company.
- ends -
For further information please contacts:
Alliance Pharma plc
John Dawson, CEO
01249 466966
Beattie Financial
Mike Wort/John Moriarty
020 7398 3300
About Alliance Pharma
Alliance Pharma, founded in 1996, is an AIM listed emerging speciality
pharmaceutical company based in Chippenham, Wiltshire. The company has a strong
track record of acquiring the rights to established niche brands and owns, or
shares, the rights to 31 branded pharmaceutical products and is currently
exploring several opportunities to expand the range. In November 2003 the
company acquired Peerless Technology Group Plc constituting a reverse takeover
under the AIM rules.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.